Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bluebird Bio

Known as: Blue Bird Biotec 
A clinical-stage biotechnology company using gene therapy, cancer immunotherapy, and gene editing to treat and cure genetic diseases and cancer.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Non-graft-vs.-host disease (non-GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT… Expand
  • figure 1
  • table 1
  • figure 2
  • table 5
Highly Cited
2018
Highly Cited
2018
Introduction: Immunomodulatory chimeric antigen receptor (CAR) T cell therapy directed against B-cell maturation antigen (BCMA… Expand
2018
2018
Abstract Protein engineering is used to generate novel protein folds and assemblages, to impart new properties and functions onto… Expand
  • table 1
  • table 1
  • figure 1
  • figure 2
  • figure 3
2018
2018
Background We reported durable responses to CD19-specific chimeric antigen receptor-modified T-cell therapy (JCAR014) in relapsed… Expand
Review
2016
Review
2016
Gene editing is a rapidly developing area of biotechnology in which the nucleotide sequence of the genome of living cells is… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2016
Highly Cited
2016
β-globin gene transfer into hematopoietic stem cells (HSCs) has the potential to reduce or eliminate the symptoms and long-term… Expand
Review
2016
Review
2016
Introduction Osteonecrosis of the femoral head (ONFH) is characterized by insidious onset of hip joint pain, limited range of… Expand
Highly Cited
2015
Highly Cited
2015
A previously published clinical trial demonstrated the benefit of autologous CD34+ cells transduced with a self-inactivating… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2015
Highly Cited
2015
  • C. Morrison
  • Nature Biotechnology
  • 2015
  • Corpus ID: 205266596
an annuity model that spreads that payment over a number of years to lessen the costdensity burden on payers; and a pay… Expand